Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Breast Cancer Hormone Therapy Related Musculoskeletal Symptoms
Trial Name: A Randomized Placebo-Controlled Phase III Study of Duloxetine For Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms In Women With Early Stage Breast Cancer.
Protocol ID: S1202
Patients must not have concurrent medical/arthritic disease that could confound or interfere with evaluation of pain or efficacy including: inflammatory arthritis (rheumatoid arthritis, systemic lupus, spondyloarthropathy, psoriatic arthritis, polymyalgia rheumatical) and cancer involving the bone.
Enrollment: • About 294 people will take part in this study at several medical centers.
Taking part in this study may or may not make your health better. We hope that the information from this study will help doctors learn whether duloxetine reduces joint pain in patients receiving aromatase inhibitors. This information could help future patients taking aromatase inhibitors.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Aspirus Regional Cancer Center Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353, or Langlade Cancer Center Research Nurse Debra Witman @ 715-623-9587.
Created: May 21, 2014
Updated: May 21, 2014